Switch to:
More From Other Websites
[video] Don't Expect Tax Inversion Fever to Break Anytime Soon Jul 22 2014
Top U.S. lawmaker wants corporate tax loophole 'plugged now' Jul 22 2014
Top U.S. lawmaker wants corporate tax loophole 'plugged now' Jul 22 2014
Top U.S. lawmaker wants corporate tax loophole 'plugged now' Jul 22 2014
U.S. Senate panel to debate wave of corporate tax-avoidance deals Jul 21 2014
[video] Obstacle races attract sponsors Jul 21 2014
[video] Spartan Race eyes Olympic placement Jul 21 2014
Tax inversions allow firms to avoid state taxes Jul 21 2014
3 Stocks Reiterated As A Buy: PFE, ORCL, PEP Jul 21 2014
Bristol-Myers/Pfizer Commence Phase IV Study on Eliquis Jul 18 2014
AbbVie Is Biggest to Quit U.S. Address in $55 Billion Shire Deal Jul 18 2014
Pep Boys, Buenaventura, Pfizer, Mylan and AstraZeneca highlighted as Zacks Bull and Bear of the Day Jul 18 2014
Is Roche Eyeing Up A Bid For AstraZeneca plc? Jul 18 2014
Is Roche Eyeing Up A Bid For AstraZeneca plc? Jul 18 2014
The Hippie Hobby Lobby: Eden Foods Says No to Birth Control Jul 18 2014
Pfizer Eyes InnoPharma, Acquisition to Boost Injectables Biz Jul 17 2014
Pfizer Bolsters Injectables by Buying InnoPharma Jul 17 2014
Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to... Jul 17 2014
Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to... Jul 17 2014


Add Notes, Comments or Ask Questions

User Comments

SEENSCO
ReplySEENSCO - 1 month ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide